Clinical trial
TNFalfa Blocking Treatment of Spondylarthropathies - A Danish Multicenter Study of New Methods for Better Monitoring and Prognostifying Patients With Spondylarthropathies
NCT00133315 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TNFalfa Blocking Treatment of Spondylarthropathies - A Danish Multicenter Study of New Methods for Better Monitoring and Prognostifying Patients With Spondylarthropathies
- Lead sponsor
- Hvidovre University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2004
- Completion date
- April 30, 2007
- Enrollment
- 50
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis, psoriatic arthritis, spondylarthropathies